Reuters logo
BRIEF-Tenax Therapeutics had $21.9 mln in cash as of December 31, 2016
March 21, 2017 / 10:09 AM / 8 months ago

BRIEF-Tenax Therapeutics had $21.9 mln in cash as of December 31, 2016

March 21 (Reuters) - Tenax Therapeutics Inc:

* Tenax Therapeutics announces year-end 2016 financial results and provides corporate update

* Tenax Therapeutics Inc- expects cash balance will be sufficient for it to accomplish its corporate goals through first half of 2018

* Tenax Therapeutics Inc- as of December 31, 2016, company had $21.9 million in cash compared to $38.2 million at December 31, 2015 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below